PLX

Protalix BioTherapeutics (DE) (PLX)

About Protalix BioTherapeutics (DE) (PLX)

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Details

Daily high

$1.76

Daily low

$1.46

Price at open

$1.73

52 Week High

$3.10

52 Week Low

$0.82

Market cap

136.8M

Dividend yield

0.00%

Volume

5.7M

Avg. volume

1.1M

P/E ratio

65.40

Protalix BioTherapeutics (DE) News